Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
1,400
-180
-11% -$120K 0.02% 413
2026
Q1
$861K Sell
1,580
-1,875
-54% -$765K 0.01% 456
2025
Q4
$1.08M Sell
3,455
-30
-0.9% -$9.52K 0.02% 411
2025
Q3
$941K Buy
3,485
+16
+0.5% +$3.67K 0.01% 453
2025
Q2
$765K Buy
+3,469
New +$625K 0.01% 483
2019
Q2
Sell
-4,500
Closed -$225K 901
2019
Q1
$225K Buy
+4,500
New +$203K 0.01% 834
2018
Q1
Sell
-4,500
Closed -$203K 909
2017
Q4
$203K Hold
4,500
0.01% 861
2017
Q3
$303K Hold
4,500
0.01% 789
2017
Q2
$270K Hold
4,500
0.01% 774
2017
Q1
$298K Hold
4,500
0.01% 765
2016
Q4
$317K Hold
4,500
0.01% 744
2016
Q3
$266K Buy
+4,500
New +$221K 0.01% 773

Other funds holding AGX

BOK Financial's AGX Position: Q2 2026 in Review

BOK Financial reduced its Argan (AGX) stake by 11% in Q2 2026, selling an estimated $120K and leaving 1,400 shares worth $1.12M. The position accounts for 0.02% of the portfolio, ranked #413.

BOK Financial first reported a position in AGX in Q3 2016 and has held it in 12 quarters since. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • BOK Financial held 1,400 shares of Argan worth $1.12M as of Q2 2026.
  • BOK Financial sold 180 Argan shares in Q2 2026, an estimated $120K.
  • Argan made up 0.02% of BOK Financial's portfolio in Q2 2026, its #413 holding.
  • BOK Financial first reported a position in Argan in Q3 2016 and has held it in 12 quarters since.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.